Launching DTC models requires navigating regulatory and licensing rules.
Spreeha Choudhury, JD, PharmD
Advertisement
Articles by Spreeha Choudhury, JD, PharmD
The idea of denying people proven medicines in the name of research has a dark legacy in this country.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
2
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
3
What Governance Resets Should Pharma Companies Take in Response to AI?
4
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
5